← Leaderboards
Martha Q Lacy
Mayo Clinic Coll Of Medicine, Rochester
$648,671
Attributed
$648,671
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $348.9K · FY2021–22$500K$375K$250K$125K$0
'21
'22
Funding mix
By agency
NIH$648,671 · 4
By mechanism
P50$645,658 · 1
M01$3,013 · 3
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Coll Of Medicine, Rochester
Same institution · by research overlap
- Stephen J Russell$9,318,537
- Roberto B. Cattaneo$13,481,773
- Jann N Sarkaria$30,462,841
- Keith C Bible$4,335,431
- Rafael Fonseca$16,992,958
Others in their field
Top investigators on “Dendritic Cells”
- Barton F Haynes · Duke University$112,608,041
- Constance Ann Benson · University Of California, San Diego$65,790,143
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- James C. Paulson · Scripps Research Institute$41,568,802
- Ulrich H Von Andrian · Harvard Medical School$32,521,007
- Donald L Morton · John Wayne Cancer Institute$29,042,629
Research focus
Dendritic CellsClinical ResearchNeoplasm /Cancer VaccineHuman Therapy EvaluationHuman SubjectAmyloidosisMultiple MyelomaImmune ResponseTransplantationNeoplasm /Cancer TherapyClinical Trial Phase IGene TherapyBlood /Lymphatic NeoplasmCellsCell KillingAnti-Pd1 AntibodiesCell DeathAnti-Pd-1AntibodiesDoseCytotoxic T-LymphocytesAntibody Titer MeasurementCancer TherapyCytolysis
Grant awards (7)
Project 1: Optimizing a VSV-based virotherapy-based regimen for advanced MM$348,913
P50 · FY2022 · CA · contact PI
Project 1: Optimizing a VSV-based virotherapy-based regimen for advanced MM$296,745
P50 · FY2021 · CA · contact PI
Dendritic Cell-Based Idiotype Vaccination with INF/IL2$1,854
M01 · FY2004 · RR
Dendritic Cell Based Vaccination with Idiotype for Amyloidosis$1,159
M01 · FY2004 · RR
DENDRITIC CELL BASED VACCINATION W/ IDIOTYPE FOR AMYLOIDOSIS &POST TRANSPLANT$0
M01 · FY2002 · RR
DENDRITIC CELL BASED VACCINATION W/ IDIOTYPE FOR AMYLOIDOSIS &POST TRANSPLANT$0
M01 · FY2001 · RR
DENDRITIC CELL BASED VACCINATION W/ IDIOTYPE FOR AMYLOIDOSIS &POST TRANSPLANT$0
M01 · FY2000 · RR